WORCESTER, Mass., June 22, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced the appointment of Stephen Fellows, CA to the position of Vice President of Finance as the Company plans for growth in sales for its current retail product portfolio and increased commercialization for its flagship Oral Insulin product Generex Oral-lyn(tm).
